SLEDD-F (Sustained low efficiency daily dia-filtration)
Overview
SLEDD-F (Sustained low efficiency daily dia-filtration) is a safe and effective method for hemodialysis inpatients with low blood pressure, heart failure, and those who have received open-heart surgery. It can help to maintain fluid balance, minimize the risk of blood pressure fluctuations, and reduce stain on the heart while removing excess fluid from the body by ultrafiltration.
Features Summary
SLEDD-F typically requires longer treatment times, ranging from 6 to 8 hours per session, compared to traditional hemodialysis methods. This is because SLEDD-F is designed to provide a gentler and more gradual removal of excess fluid and waste products from the blood, which can be better tolerated by patients who are more sensitive to rapid changes in fluid balance.
Procedure
The SLEDD-F procedure involves the following steps:
1.An arteriovenous fistula, arteriovenous graft, or a double lumen catheter will be established as a vascular access for SLEDD-F. The catheter would be inserted into a large vein in the patient's neck, chest, or groin.
2.After puncturing the arteriovenous shunt or connecting the circuit with the double-lumen catheter by a dialysis nurse, your blood is drawn out from the vascular access, pumped through the dialyzer, and then pumped back.
3.Uremic toxins and excess fluid will be removed from the blood to the dialysate, which is composed of minerals and high quality water from a water purification system. Blood pressure and heart rate are closely monitored. An anticoagulant like heparin is used to prevent intraluminal thrombosis. At the end of the treatment, puncture site hemostasis is ensured by a dialysis nurse.
4.The SLEDD-F treatment usually lasts for 6-8 hours per session, and is typically performed on a daily basis to provide continuous removal of excess fluid and waste products from the body.
Notification
Like any medical procedure, SLEDD-F carries some potential risks and complications, although these are generally less common than with traditional hemodialysis methods. Some of the potential risks and complications associated with SLEDD-F include:
Hypotension: Low blood pressure can occur during SLEDD-F, especially in patients who are more sensitive to changes in fluid balance. Hypotension can cause dizziness, nausea, or even loss of consciousness.
Bleeding and infection: Inserting a catheter into a vein can cause bleeding or introduce an infection into the bloodstream. Proper sterile technique and catheter care can minimize the risk of infection and bleeding.
Electrolyte imbalances: SLEDD-F can alter the balance of electrolytes in the bloodstream, which can cause muscle weakness, cramps, or irregular heart rhythms.
Fluid imbalances: SLEDD-F can cause changes in fluid balance, which can lead to dehydration or fluid overload.
Cardiovascular events: SLEDD-F can increase the risk of cardiovascular events such as heart attack or stroke, especially in patients with underlying cardiovascular disease.
Air embolism: Air bubbles in the bloodstream can occur if the catheter is not properly inserted or maintained.
Allergic reaction: Patients may have an allergic reaction to the dialysate fluid or other components of the SLEDD-F equipment.
It's important to note that the risk of these complications can be minimized by careful monitoring during treatment, and proper sterile technique and catheter care. Patients who experience any unusual symptoms or side effects during SLEDD-F should notify their healthcare provider immediately.
Estimated Cost
For estimated medical costs, please contact International Medical Services Center.